Robotic Surgery in Pediatric Oncology: Lessons Learned from the First 100 Tumors-A Nationwide Experience
- PMID: 34523002
- DOI: 10.1245/s10434-021-10777-6
Robotic Surgery in Pediatric Oncology: Lessons Learned from the First 100 Tumors-A Nationwide Experience
Erratum in
-
Correction to: Robotic Surgery in Pediatric Oncology: Lessons Learned from the First 100 Tumors-A Nationwide Experience.Ann Surg Oncol. 2021 Dec;28(Suppl 3):901. doi: 10.1245/s10434-021-10861-x. Ann Surg Oncol. 2021. PMID: 34601667 No abstract available.
Abstract
Background: While robotics has become commonplace in adult oncology, it remains rare in pediatric oncology due to the rarity of childhood cancers. We present the results of a large nationwide experience with robotic oncology, with the aim of providing practical and feasible guidelines for child selection.
Methods: This was a prospective analysis performed over a period of 4 years. Treatment was delivered according to the Société Internationale d'Oncologie Pédiatrique/International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOP/SIOPEN) protocols. Indications were approved by a certified tumor board.
Results: Overall, 100 tumors were resected during 93 procedures (abdomen, 67%; thorax, 17%; pelvis, 10%; retroperitoneum, 6%) in 89 children (56 girls). The median age at surgery was 8.2 years (range 3.6-13); 19 children (21%) harbored germinal genetic alterations predisposing to cancer. No intraoperative tumor ruptures occurred. Seven conversions (8%) to an open approach were performed. Neuroblastic tumors (n = 31) comprised the main group (18 neuroblastomas, 4 ganglioneuroblastomas, 9 ganglioneuromas) and renal tumors comprised the second largest group (n = 24, including 20 Wilms' tumors). The remaining 45 tumors included neuroendocrine (n = 12), adrenal (n = 9), germ-cell (n = 7), pancreatic (n = 4), thymic (n = 4), inflammatory myofibroblastic (n = 4), and different rare tumors (n = 5). Overall, 51 tumors were malignant, 2 were borderline, and 47 were benign. The median hospital stay was 3 days (2-4), and five postoperative complications occurred within the first 30 days. During a median follow-up of 2.4 years, one child (Wilms' tumor) presented with pleural recurrence. One girl with Wilms' tumor died of central nervous system metastasis.
Conclusions: Robotic surgery for pediatric tumors is a safe option in highly selected cases. Indications should be discussed by tumor boards to avoid widespread and uncontrolled application.
© 2021. Society of Surgical Oncology.
Similar articles
-
Robotic-assisted laparoscopic management of renal tumors in children: Preliminary results.Pediatr Blood Cancer. 2019 Aug;66 Suppl 3:e27867. doi: 10.1002/pbc.27867. Epub 2019 May 28. Pediatr Blood Cancer. 2019. PMID: 31136081
-
Laparoscopic treatment of renal cancer in children: a multicentric study and review of oncologic and surgical complications.J Pediatr Urol. 2014 Jun;10(3):500-5. doi: 10.1016/j.jpurol.2013.11.005. Epub 2013 Nov 25. J Pediatr Urol. 2014. PMID: 24332932
-
Wilms' tumor--single-center experience with renal surgery.Scand J Urol Nephrol. 2004;38(5):373-7. doi: 10.1080/00365590310025514. Scand J Urol Nephrol. 2004. PMID: 15764247
-
[Wilm's tumor 1992. State of research and results of current therapeutic concepts].Urologe A. 1992 Nov;31(6):360-7. Urologe A. 1992. PMID: 1334295 Review. German.
-
Wilms' tumor- roadmaps of management.Indian J Pediatr. 2012 Jun;79(6):776-86. doi: 10.1007/s12098-012-0747-3. Epub 2012 May 4. Indian J Pediatr. 2012. PMID: 22555907 Review.
Cited by
-
Robotic-assisted laparoscopy in pediatric surgical oncology: a narrative review.Transl Pediatr. 2023 Dec 26;12(12):2256-2266. doi: 10.21037/tp-23-251. Epub 2023 Dec 18. Transl Pediatr. 2023. PMID: 38197107 Free PMC article. Review.
-
Current trends and prospects of surgical techniques for hepatoblastoma.Cancer Med. 2024 Jan 5;13(1):e6795. doi: 10.1002/cam4.6795. Online ahead of print. Cancer Med. 2024. PMID: 38180290 Free PMC article. Review.
-
Surgery in Bilateral Wilms Tumor-A Single-Center Experience.Children (Basel). 2023 Nov 7;10(11):1790. doi: 10.3390/children10111790. Children (Basel). 2023. PMID: 38002881 Free PMC article.
-
Narrative review: robotic pediatric surgery-current status and future perspectives.Transl Pediatr. 2023 Oct 30;12(10):1875-1886. doi: 10.21037/tp-22-427. Epub 2023 Oct 12. Transl Pediatr. 2023. PMID: 37969127 Free PMC article. Review.
-
Prechemotherapy Transperitoneal Robotic-Assisted Partial Nephrectomy (RAPN) for a Wilms Tumor: Surgical and Oncological Outcomes in a Four-Year-Old Patient.Pediatr Rep. 2023 Sep 21;15(3):560-570. doi: 10.3390/pediatric15030051. Pediatr Rep. 2023. PMID: 37755411 Free PMC article.
References
-
- Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Atun R. Estimating the total incidence of global childhood cancer: a simulation-based analysis. Lancet Oncol. 2019;20(4):483–93. https://doi.org/10.1016/S1470-2045(18)30909-4 . - DOI - PubMed
-
- Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103. https://doi.org/10.3322/caac.21219 . - DOI - PubMed
-
- Gatta G, Mallone S, van der Zwan JM, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15(1):23–34. https://doi.org/10.1016/S1470-2045(13)70546-1 . - DOI
-
- Christison-Lagay ER, Thomas D. Minimally invasive approaches to pediatric solid tumors. Surg Oncol Clin N Am. 2019;28(1):129–46. https://doi.org/10.1016/j.soc.2018.07.005 . - DOI - PubMed
-
- Vujanić GM, Gessler M, Ooms AHAG, et al. The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol. Nat Rev Urol. 2018;15(11):693–701. https://doi.org/10.1038/s41585-018-0100-3 . - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
